who discovered glp 1 drugs The Discovery of Glucagon-Like Peptide (GLP-1) The Brief A new NIH-funded

Eglovitch at RAPS

Retatrutide works like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) to promote weight loss, but it acts at three receptors at once and exerts the following actions: GLP-1 receptor agonism As a glucagon-like peptide-1 (GLP-1) receptor agonist, retatrutide has the following effects: The medication increases insulin secretion and reduces glucagon secretion from the pancreas, which helps lower blood sugar levels

doi: 10.1523/JNEUROSCI.21-08-02580.2001, 204 TongZ.DengW.HuangX.DongH.LiJ.ZhaoF.et al

Physiology 29, 325333 (2014)

Biochem Biophys Res Commun 117, 788793.Google Scholar EC 1.11.1.9) and superoxide dismutase ( EC 1.15.1.1) activities in riboflavin-deficient rats infected with Plasmodium berghei malaria